For studying the effect of the interaction of alloHCT and the respective IDH submutational groups on outcome, we performed interaction analysis with the interaction of alloHCT and IDHWT AML patients as the reference term (Fig. 6a for OS, Fig. 6b for RFS). The gene discussed is IDH2; the disease is acute myeloid leukemia.